Netherlands· NL-ccaf42f5c9f8

Dolamizol 250 mg, tablet

A metamizole sodium product containing metamizolnatrium 1-water, registered in Netherlands by All-Gen Pharmaceuticals & Generics B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC N02BB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about metamizolnatrium 1-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Metamizole sodium is registered in 8 of 19 countries.

Countries holding a registration under ATC N02BB02 (metamizole sodium), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search metamizole sodium products by name

Metamizole sodium · ATC N02BB02

8 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metamizole sodium costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Metamizole sodium · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$3.00

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: METAMIZOLNATRIUM 1-WATER
Manufacturer: All-Gen Pharmaceuticals & Generics B.V.
Country: Netherlands (NL)
ATC code: N02BB02
ATC class: Metamizole sodium
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
124159

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for metamizole sodium.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check metamizole sodium against other medicines How interaction checks work

Metamizole sodium · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metamizole sodium in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metamizole sodium products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Metagelan, Metamizol +pharma
Belgium · Novalgine, Novalgine I.M./I.V.
Bulgaria · Hexalgin, Аналгин Макс
Czechia · Afexil, Algominal
Germany · Analgin, Analgin Ampullen
Spain · Metamizol Basi, Metamizol Normon
Greece · Elgopas
Croatia · Alkagin, Analgin
Hungary · Algopyrin, Dolosped
Lithuania · Analgin, Metamizole Sodium Kalceks
Luxembourg · Novalgine I.M./I.V.
Poland · Algedon, Axonalgin
Portugal · Dolocalma, Metamizol Aristo
Romania · Algiotop, Algocalmin
Slovenia · Algominal, Analgin
Slovakia · Emitazem, Metamistad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0a2f6d15-30d3-4f1e-8346-94b2d437aa47
GET /v1/drugs/0a2f6d15-30d3-4f1e-8346-94b2d437aa47?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124159_smpc.pdf",
  "strength": null,
  "atc_label": "Metamizole Sodium",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124159",
  "excipients": [
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 25 (E 1201)",
    "TALK (E 553b)"
  ],
  "substances": [
    "METAMIZOLNATRIUM 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124159.pdf",
  "authorised_at": "2021/03/18",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124159",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about metamizole sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console